Lizabeth Leveille

Liz brings over 17 years industry experience and over the past 14 years has focused her work in business development at large pharmaceutical companies. She is currently the Head of the Merck Boston Innovation Hub, which is a Business Development & Licensing team focused on early-stage therapeutics (prior to human proof-of-concept) as well as accessing innovative research and technologies through collaboration, licensing, or M&A in the academic, pharma, and biotech community. Previous to Merck, she spent nine years at the Novartis Institutes for BioMedical Research (NIBR) in the Strategic Alliances department. During her time at NIBR, her roles included search and evaluation activities as well as leading the negotiation of licensing, collaboration, and M&A transactions including Novartis’ acquisition of CoStim Pharmaceuticals and licensing deals with Servier, Peptidream, among others.

Liz also has industry experience in scientific roles, given her time at companies such as AVEO Pharmaceuticals, Akceli, Millennium, and Genzyme. Liz has a Masters degree in Biotechnology from Worcester Polytechnic Institute and a MBA from the F.W. Olin Graduate School of Business at Babson College.